Our results indicate that Scrib inhibited HCC cell proliferation and liver tumor growth by suppressing Yap1, c-Myc and cyclin D1 via the ERK and Hippo signaling pathways. The gene discussed is MYC; the disease is hepatocellular carcinoma.